Resistant Kawasaki disease

Journal of Paediatrics and Child Health

Volumn 40, Issue 9-10, 2004, Pages 576-578

  Nachiappan, J ^a,b   May, M ^a   Hawker, R E ^a   Hong, P ^a  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b Depts of Immunol and Infect Dis   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PENICILLIN G;

ANAMNESIS; ARTICLE; CARDIOVASCULAR RISK; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; CONJUNCTIVITIS; CORONARY ARTERY ANEURYSM; DIAGNOSTIC APPROACH ROUTE; DRUG MEGADOSE; ECHOCARDIOGRAPHY; FEVER; HOSPITAL ADMISSION; HUMAN; LABORATORY TEST; LYMPHADENOPATHY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL; RASH; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; TEMPERATURE MEASUREMENT;

CHILD, PRESCHOOL; FEVER; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; METHYLPREDNISOLONE; MUCOCUTANEOUS LYMPH NODE SYNDROME; TIME FACTORS; TREATMENT OUTCOME;

EID: 6344229615     PISSN: 10344810     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1754.2004.00467.x     Document Type: Article

References (20)

1. Freeman AF, Shulman ST. Recent developments in Kawasaki disease Curr. Opin. Infect. Dis 2001; 14: 357-61.
2. Smith PK, Goldwater PN. Kawasaki disease in Adelaide: A review. J. Paediatr. Child Health 1993; 29: 126-31.
3. Newburger JW, Takahashi M, Burns JC et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N. Engl. J. Med. 1986; 315: 341-7.
4. Newburger JW, Takahashi M, Beiser AS et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N. Engl. J. Med. 1991; 324: 1633-9.
5. Zhang T, Yanagawa H, Oki I et al. Factors related to cardiac sequelae of Kawasaki disease. Eur. J. Pediatr. 1999; 158: 694-7.
6. Terai M, Shulman ST. Prevalance of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose. J. Pediatr. 1997; 131: 888-93.
7. Saulsbury FT. Comparison of high dose and lowdose asprin plus intravenous immunoglobulin in the treatment of Kawasaki Syndrome. Clin. Pediatr. 2002; 41: 597-601.
8. Zhang T, Yanagawa H, Oki I, Nakamura Y. Factors relating to the cardiac sequelae of Kawasaki disease one month after initial onset. Acta Paediatr. 2002; 91: 517-20.
9. Mori M, Imagawa T, Yasui K, Kanaya A, Yokota SJ. Predictors of coronary artery lesions after intravenous gamma-globulin treatment in Kawasaki disease. Pediatr. 2000; 137: 177-80.
10. Wallace CA, French JW, Kahn SJ, Sherry DD. Initial intravenous gammaglobulin treatment failure in Kawasaki disease. Pediatr. 2000; 105: E78.
11. Han RK, Silverman ED, Newman A, McCrindle BW. Management and outcome of persistent or recurrent fever after initial intravenous gamma globulin therapy in acute Kawasaki disease. Arch. Pediatr. Adolesc. Med. 2000; 154: 694-9.
12. Burns JC, Capparelli EV, Brown JA, Newburger JW, Glode MP. Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US/Can Kawasaki Syndrome Study Group Pediatr. Infect. Dis. J. 1998; 17: 1144-8.
13. Gidding SS, Duffy CE, Pajcic S, Berdusis K, Shulman ST. Usefulness of echocardiographic evidence of pericardial effusion and mitral regurgitation during the acute stage in predicting development of coronary arterial aneurysms in the late stage of Kawasaki disease. Am. J. Cardiol. 1987; 60: 76-9.
14. Hashino K, Ishii M, Iemura M, Akagi T, Kato H. Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy. Pediatr. Int. 2001; 43: 211-17.
15. Sundel RP, Baker AL, Fulton DR, Newburger JW. Corticosteroids in the initial treatment of Kawasaki Disease: Report of a randomised trial. J. Pediatr. 2003; 142: 611-16.
16. Dale RC, Saleem MA, Daw S, Dillon MJ. Treatment of severe complicated Kawasaki disease with oral prednisolone and aspirin. J. Pediatr. 2000; 137: 723-6.
17. Shinohara M, Sone K, Tomomasa T, Morikawa A. Corticosteroids in the treatment of the acute phase of Kawasaki disease. J. Pediatr. 1999; 135: 465-9.
18. Wright DA, Newburger JW, Baker A, Sundel RP. Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids. J. Pediatr. 1996; 128: 146-9.
19. Raman V, Kim J, Sharkey A, Chatila T. Response of refractory Kawasaki disease to pulse steroid and cyclosporin A therapy. Pediatr. Infect. Dis. J. 2001; 20: 635-7.
20. Lee MS, An SY, Jang GC, Kim DS. A case of intravenous immunoglobulin-resistant Kawasaki disease treated with methotrexate. Yonsei Med. J. 2002; 43: 527-32.